CyGenics Acquires Stake in DNAPro in Exchange for Cell Sciences Subsidiary
CyGenics Acquires Stake in DNAPro in Exchange for Cell Sciences Subsidiary
CyGenics Expands into Revenue Generating Clinical Cell Therapy
First Cystic Fibrosis Cord Blood Collection